Procept Biorobotics (PRCT) revenue breakdown
By region, U.S. is the largest at 88% of fiscal 2025 revenue, growing 131% a year over 5 years.
Revenue by region
Fiscal years, as Procept Biorobotics reports them in its 10-K filings; fiscal 2025 total $308M.
| Regions | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|
| U.S. | $4M | $29M | $68M | $124M | $200M | $270M | 88% |
| Non-US | $4M | $6M | $7M | $12M | $24M | $38M | 12% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PRCT.
Open PRCT in InvestinglyQuestions
Where does Procept Biorobotics make its money?
In fiscal 2025, by region: U.S. $270M, Non-US $38M.
From Procept Biorobotics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.